Skip to content

Capital World Investors: NG position timeline

Available 13F reports, 13D and 13G stakes and each Form 3, 4 and 5 line of Capital World Investors on NG, newest first. How the timeline and the estimate are built.

Capital World Investors held 10,614,810 NG shares at 2026-06-30 per its 13F-HR filed 2026-08-12.

the latest 13F is the newest step

  1. period ended2026-06-30
    13F 10,614,810 shares
    Change vs previous 13F -1,718,190 shares

    0.01% of the 13F portfolio, value $63,370,416.

    13F-HR 0001422849-26-000113 filed by Capital World Investors
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  2. period ended2026-03-31
    13F 12,333,000 shares
    Change vs previous 13F 0 shares

    0.02% of the 13F portfolio, value $110,750,340.

    13F-HR 0001422849-26-000046 filed by Capital World Investors
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  3. period ended2025-12-31
    13F 12,333,000 shares
    Change vs previous 13F -5,333,000 shares

    0.02% of the 13F portfolio, value $114,943,560.

    13F-HR 0001422849-26-000010 filed by Capital World Investors
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  4. period ended2025-09-30
    13F 17,666,000 shares
    Change vs previous 13F +2,000,000 shares

    0.02% of the 13F portfolio, value $155,460,800.

    13F-HR 0001422849-25-000069 filed by Capital World Investors
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  5. period ended2025-06-30
    13F 15,666,000 shares
    Change vs previous 13F not available

    0.01% of the 13F portfolio, value $64,073,940.

    13F-HR 0001422848-25-000151 filed by Capital World Investors
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).